iStent - A New Treatment for Glaucoma
What is iStent?
The iStent Trabecular Micro-Bypass stent is a new surgical therapy for glaucoma that is designed to improve aqueous outflow to safely lower IOP and may reduce medication burden; but this will be at the discretion of your physician. iStent is the smallest medical device ever approved by the FDA and is placed in your eye during cataract surgery. It is so small, you won’t be able to see or feel it after surgery but it will be continuously working to help reduce your eye pressure.
|iStent is the first MIGS device that improves your eye’s natural fluid outflow to safely lower eye pressure by creating a permanent opening in the trabecular meshwork.
How can iStent help me?
Every day, you are probably taking one or more eye drops to control your eye pressure. By improving the outflow of fluid from your eyes, iStent works to help control your eye pressure. After implantation of iStent, many patients are able to control their eye pressure. Controlling eye pressure is extremely important to reduce the risk for vision loss due to glaucoma. If you forget to take your eye drops or ‘skip a dose’, this can cause large changes in your eye pressure. Large changes in eye pressure can increases the risk for vision loss. If you have both glaucoma and cataracts, ask your eye doctor if iStent is right for you.
Over 260 of the company’s telescope implants have been used in clinical trials that have generated extensive long-term safety and efficacy data. The pivotal IMT002 clinical trial, conducted across 28 leading U.S. ophthalmic centers, demonstrated the majority of patients gained at least 3 lines of visual acuity on the study eye chart and clinically meaningful quality-of-life improvements on the National Eye Institute Visual Function Questionnaire. Ten peer-reviewed publications discussing the clinical and scientific data have appeared in top-tier ophthalmic journals.
iStent: a new treatment for glaucoma
If you have glaucoma and cataracts, iStent is designed to improve your eye’s natural fluid outflow to safely lower eye pressure by creating a permanent opening in the trabecular meshwork. Proven safe and effective, the iStent Trabecular Micro-Bypass is a surgical therapy that:
- Is safely implanted during cataract surgery
- Spares important eye tissue that is often damaged by traditional surgeries
- Does not limit treatment options that could help maintain your vision in the future
iStent is the smallest medical device ever approved by the FDA and is placed in your eye during cataract surgery. It is so small, you won’t be able to see or feel it after the procedure is over. By creating a permanent opening in your trabecular meshwork, iStent is designed to improve the outflow of fluid from your eyes and help control eye pressure.
Contact us about the iStent by calling 541-687-2110 or using our Contact Form.
More Information on Glaucoma:
Glaucoma Overview Website
Common Questions About iStent
Feel free to call or drop in if you'd like to speak to someone in person.
Commonly Asked Questions:
How do I find out if I have Glaucoma?
Early detection is crucial. Your doctor will perform a painless test
to measure the fluid pressure and evaluate the retina and optic nerve.
If the pressure is unusually high or if the optic nerve proves abnormal
upon examination, your doctor will suggest you undergo a "visual
fields" test to determine if any peripheral or side vision has
been lost. Read
more about the visual test here.
In a US Clinical Study 68% of patients who received iStent remained medication-free at 12 months, while sustaining a target IOP of <21 MM HG vs. only 50% of patients who underwnet cataract surger alone.